These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A review of co-milling techniques for the production of high dose dry powder inhaler formulation. Lau M; Young PM; Traini D Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654 [TBL] [Abstract][Full Text] [Related]
24. Inhaled corticosteroid delivery systems: clinical role of a breath-actuated device. Donnell D Eur Rev Med Pharmacol Sci; 2001; 5(1):7-16. PubMed ID: 11860222 [TBL] [Abstract][Full Text] [Related]
25. Advances in inhalation therapy in pediatrics. Muchão FP; Filho LV J Pediatr (Rio J); 2010; 86(5):367-76. PubMed ID: 20938588 [TBL] [Abstract][Full Text] [Related]
26. Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices. Lipworth BJ; Clark DJ Pulm Pharmacol Ther; 1997 Aug; 10(4):211-4. PubMed ID: 9695144 [TBL] [Abstract][Full Text] [Related]
27. The History of Therapeutic Aerosols: A Chronological Review. Stein SW; Thiel CG J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):20-41. PubMed ID: 27748638 [TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy and safety of Turbuhaler as compared to pressurized MDIs-beta 2-agonists. Laursen LC J Aerosol Med; 1994; 7(Suppl 1):S59-62. PubMed ID: 10161099 [TBL] [Abstract][Full Text] [Related]
30. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Gabrio BJ; Stein SW; Velasquez DJ Int J Pharm; 1999 Sep; 186(1):3-12. PubMed ID: 10469919 [TBL] [Abstract][Full Text] [Related]
31. Probability of particle and salbutamol deposition in the respiratory tract: comparison between MDI and Autohaler. Terzano C; Mannino F Monaldi Arch Chest Dis; 1996 Jun; 51(3):236-42. PubMed ID: 8766201 [TBL] [Abstract][Full Text] [Related]
32. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Laube BL Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400 [TBL] [Abstract][Full Text] [Related]
33. [Update on inhalation therapy in asthma and obstructive bronchopulmonary diseases]. Boulet LP; d'Amours P; Bérubé D; Rouleau M; Parent JG; Pelletier C; Touchette C Union Med Can; 1994 Jan; 123(1):23-31. PubMed ID: 8109063 [TBL] [Abstract][Full Text] [Related]
34. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence. Aggarwal B; Gogtay J Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511 [TBL] [Abstract][Full Text] [Related]
36. State of the art and new perspectives on dry powder inhalers. Terzano C; Colombo P Eur Rev Med Pharmacol Sci; 1999; 3(6):247-54. PubMed ID: 11261735 [TBL] [Abstract][Full Text] [Related]
37. Clinical assessment of a new breath-actuated inhaler. Crompton G; Duncan J Practitioner; 1989 Feb; 233(1463):268-9. PubMed ID: 2587490 [TBL] [Abstract][Full Text] [Related]
38. Targeting drugs to the airways: The role of spacer devices. Lavorini F; Fontana GA Expert Opin Drug Deliv; 2009 Jan; 6(1):91-102. PubMed ID: 19236210 [TBL] [Abstract][Full Text] [Related]
39. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler. Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377 [TBL] [Abstract][Full Text] [Related]
40. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD]. Henriet AC; Marchand-Adam S; Mankikian J; Diot P Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]